Literature DB >> 14846796

Experimental studies on passive immunization against poliomyelitis. I. Protection with human gamma globulin against intramuscular inoculation, and combined passive and active immunization.

D BODIAN.   

Abstract

Entities:  

Keywords:  GLOBULINS; POLIOMYELITIS

Mesh:

Substances:

Year:  1951        PMID: 14846796     DOI: 10.1093/oxfordjournals.aje.a119463

Source DB:  PubMed          Journal:  Am J Hyg        ISSN: 0096-5294


× No keyword cloud information.
  11 in total

1.  [Prevention of poliomyelitis; present and future].

Authors:  P LEPINE
Journal:  Bull World Health Organ       Date:  1955       Impact factor: 9.408

2.  Day-by-day response of vaccinated chimpanzees to poliomyelitic infection.

Authors:  H HOWE
Journal:  Am J Public Health Nations Health       Date:  1957-07

3.  Poliomyelitis vaccine studies.

Authors:  G C BROWN; A S RABSON; D E CRAIG
Journal:  Public Health Rep       Date:  1956-06       Impact factor: 2.792

4.  [Virus diseases in otorhinolaryngology region].

Authors:  R HAAS
Journal:  Arch Ohren Nasen Kehlkopfheilkd       Date:  1955-05-02

5.  [Model studies on the problem of viremia in mumps infection].

Authors:  H LIPPELT; F MULLER
Journal:  Z Hyg Infektionskr       Date:  1954

6.  Immunization against poliomyelitis.

Authors:  T E BOYD
Journal:  Bacteriol Rev       Date:  1953-12

7.  Avenues of Approach Toward the Control of Poliomyelitis.

Authors: 
Journal:  Am J Public Health Nations Health       Date:  1952-12

8.  Haematogenous spread of poliomyelitis virus.

Authors:  J D VERLINDE; B BEEM
Journal:  Antonie Van Leeuwenhoek       Date:  1952       Impact factor: 2.271

9.  Passive immunization against poliomyelitis: the Hammon gamma globulin field trials, 1951-1953.

Authors:  Charles R Rinaldo
Journal:  Am J Public Health       Date:  2005-05       Impact factor: 9.308

10.  Levels of homotypic neutralizing antibody in human poliomyelitis three years after infection.

Authors:  J WINSSER; A B SABIN
Journal:  J Exp Med       Date:  1952-11       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.